PHARMAC

Pharmac – Te Pātaka Whaioranga is funding two new cancer treatments, for advanced breast cancer, and for blood cancer, which will improve health outcomes for hundreds of New Zealanders. Learn more: bit.ly/2024-02-15Consultatio…

Pharmac – Te Pātaka Whaioranga is funding two new cancer treatments, for advanced breast cancer, and for blood cancer, which will improve health outcomes for hundreds of New Zealanders. Learn more: bit.ly/2024-02-14-Notificati…

Last week our @Tuputoa_NZ interns presented their research projects and reflected on their time at Te Pātaka Whaioranga - Pharmac. Learn more about our interns: bit.ly/2024-02-12-Tuputoa-In…

Pharmac – Te Pātaka Whaioranga is funding testosterone gel without restrictions as an additional testosterone treatment for anyone who needs it from 1 April 2024. Learn more: bit.ly/2024-02-08Notificatio…

Pharmac – Te Pātaka Whaioranga is seeking feedback on a joint proposal with Health New Zealand – Te Whatu Ora, to enable community pharmacies to give some of the funded childhood vaccines. Learn more: bit.ly/2024-01-14Consultatio…

Pharmac – Te Pātaka Whaioranga is funding more nutritional supplements for people with inherited metabolic diseases from 1 February 2024. Learn more: bit.ly/2024-01-11FundingNoti…

Pharmac – Te Pātaka Whaioranga is seeking feedback on a proposal to fund two new treatments for advanced breast cancer and a type of blood cancer. The treatments are ribociclib (branded as Kisqali) and midostaurin (branded as Rydapt). Find out more bit.ly/2023-12-12consultatio…

Pharmac is widening access to COVID-19 antivirals to people who are vulnerable to severe infection from COVID-19, including those with disabilities and with one or more severe health conditions. Learn more: bit.ly/2023-09-20CovidNotifi…

Applications for the Hiwinui Heke Māori Pharmacy Scholarships are now open. Te Pātaka Whaioranaga in collaboration with Ngā Kaitiaki o Te Puna Rongoā o Aotearoa (Māori Pharmacists Association) is proud to offer this opportunity. Applications close 31 Oct. bit.ly/māoripharmacystudents

The September edition of the Kauneke Update is out now. In this update we have a video from our Director of Strategy, Policy, and Performance talking about 30 years of Pharmac, the Pharmac Review, and our new Statement of Intent. View the update: bit.ly/2023-09-04KaunekeUpda…

Pharmac has confirmed it is widening access to two treatments today, emicizumab for the treatment of people with severe haemophilia A, and ocrelizumab for primary progressive multiple sclerosis. Learn more: bit.ly/2023-09-04Haemophilia bit.ly/2023-09-04MultipleScl…